Choreo LLC Buys Shares of 160,867 Connect Biopharma Holdings Limited (NASDAQ:CNTB)

Choreo LLC purchased a new stake in shares of Connect Biopharma Holdings Limited (NASDAQ:CNTBFree Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 160,867 shares of the company’s stock, valued at approximately $204,000. Choreo LLC owned 0.29% of Connect Biopharma at the end of the most recent quarter.

Separately, BML Capital Management LLC raised its stake in Connect Biopharma by 2.4% during the third quarter. BML Capital Management LLC now owns 2,093,232 shares of the company’s stock valued at $3,014,000 after buying an additional 49,984 shares in the last quarter. 58.72% of the stock is currently owned by institutional investors.

Connect Biopharma Stock Performance

Shares of NASDAQ CNTB opened at $0.92 on Friday. The stock’s 50 day moving average price is $1.06 and its two-hundred day moving average price is $1.14. Connect Biopharma Holdings Limited has a 52-week low of $0.91 and a 52-week high of $2.66.

Connect Biopharma Profile

(Free Report)

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets.

Further Reading

Institutional Ownership by Quarter for Connect Biopharma (NASDAQ:CNTB)

Receive News & Ratings for Connect Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Connect Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.